Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures
- PMID: 24486959
- DOI: 10.1016/j.neuro.2014.01.006
Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures
Abstract
Research indicates that inflammation and microglial activation are involved in the initiation and progression of Parkinson's disease (PD). Neuroinflammation contributes to the infiltration of peripheral immune cells and blood-brain barrier (BBB) leakage, linking peripheral and central inflammatory events in the pathogenesis of PD. Dopamine (DA) likely plays a role in this process. In the present study, the dopaminergic toxin 6-hydroxydopamine (6-OHDA) was used to damage dopaminergic neurons. Injection of 6-OHDA within the nigrostriatal pathway produced loss of astrocytes, disruption of the BBB, microglia activation and a reduction in osteopontin (OPN) immunoreactivity. Depletion of DA content by alpha-methylparatyrosine (α-MPT, a tyrosine hydroxylase inhibitor) reduced the infiltration of peripheral macrophages as well as the 6-OHDA-induced increase in microglial cells. DA could therefore be relevant in sustaining inflammation and lymphocyte recruitment induced by 6-OHDA, supporting DA implication in the degeneration of dopaminergic neurons induced by inflammatory processes.
Keywords: Dopaminergic brain structures; Inflammation; Macrophages; Monocytes infiltration; Neurodegeneration.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.Exp Neurol. 2007 Sep;207(1):95-106. doi: 10.1016/j.expneurol.2007.05.030. Epub 2007 Jun 18. Exp Neurol. 2007. PMID: 17643430
-
Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.Exp Neurol. 1997 Aug;146(2):526-35. doi: 10.1006/exnr.1997.6575. Exp Neurol. 1997. PMID: 9270064
-
Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.Neuropharmacology. 2013 Feb;65:48-57. doi: 10.1016/j.neuropharm.2012.08.023. Epub 2012 Sep 7. Neuropharmacology. 2013. PMID: 22982254
-
Smoking, nicotine and Parkinson's disease.Trends Neurosci. 2004 Sep;27(9):561-8. doi: 10.1016/j.tins.2004.06.008. Trends Neurosci. 2004. PMID: 15331239 Review.
-
Inflammation in Parkinson's disease: role of glucocorticoids.Front Neuroanat. 2015 Apr 2;9:32. doi: 10.3389/fnana.2015.00032. eCollection 2015. Front Neuroanat. 2015. PMID: 25883554 Free PMC article. Review.
Cited by
-
Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes.J Mol Neurosci. 2019 Sep;69(1):1-16. doi: 10.1007/s12031-018-1181-4. Epub 2018 Oct 20. J Mol Neurosci. 2019. PMID: 30343367
-
Osteopontin expression in the brain triggers localized inflammation and cell death when immune cells are activated by pertussis toxin.Mediators Inflamm. 2014;2014:358218. doi: 10.1155/2014/358218. Epub 2014 Nov 24. Mediators Inflamm. 2014. PMID: 25525298 Free PMC article.
-
Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.J Neuroinflammation. 2021 Dec 17;18(1):292. doi: 10.1186/s12974-021-02338-1. J Neuroinflammation. 2021. PMID: 34920747 Free PMC article.
-
Infectious immunity in the central nervous system and brain function.Nat Immunol. 2017 Feb;18(2):132-141. doi: 10.1038/ni.3656. Epub 2017 Jan 16. Nat Immunol. 2017. PMID: 28092376 Free PMC article. Review.
-
The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease.Biochem Soc Trans. 2023 Apr 26;51(2):747-758. doi: 10.1042/BST20201091. Biochem Soc Trans. 2023. PMID: 37013975 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
